Study of V617F JAK2-positive and JAK2-negative patients within 18 families with myeloproliferative disorders (MPD): Disease characteristics and evolution, EPOR and MPL analysis.

被引：0
|
作者：
Bellanne-Chantelot, Christine
Labopin, Myriam
Bellanger, Florence
Chaumarel, Isabelle
Isnard, Franpoise
Casadevall, Nicole
Vainchenker, William
Thomas, Gilles
Najman, Albert
机构：
[1] Univ Paris 06, Dept Genet, APHP St Antoine, Paris, France
[2] INSERM, U790, IGR, Villejuif, France
[3] Dept Canc Epidemiol & Genet, Gaithersburg, MD USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
672
引用
收藏
页码：202A / 202A
页数：1
相关论文
共 50 条
  • [1] Comparison of JAK2 V617F positive and negative myeloproliferative diseases
    Szilvasi, A.
    Andrikovics, H.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 379 - 379
  • [2] The JAK2 V617F mutation in the myeloproliferative disorders
    Sale, MA
    Awan, A
    Lucas, GS
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 33 - 33
  • [3] JAK2 V617F mutation and the myeloproliferative disorders
    Vainchenker, William
    Casadevall, Nicole
    HEMATOLOGIE, 2006, 12 (01): : 3 - 7
  • [4] The V617F JAK2 mutation and the myeloproliferative disorders
    Percy, MJ
    McMullin, MF
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
  • [5] Clinical characteristics of JAK2 V617F positive myeloproliferative diseases
    Andrikovics, H.
    Szilvasi, A.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    BLOOD REVIEWS, 2007, 21 : S124 - S124
  • [6] Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
    Pietra, Daniela
    Li, Sai
    Brisci, Angela
    Passarnonti, Francesco
    Rumi, Elisa
    Theocharides, Alexandre
    Ferrari, Maurizio
    Gisslinger, Heinz
    Kralovics, Robert
    Cremonesi, Laura
    Skoda, Radek
    Cazzola, Mario
    BLOOD, 2008, 111 (03) : 1686 - 1689
  • [7] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [8] JAK2V617F mutation detection in myeloproliferative disorders (MPD)
    Bakkus, M. H. C.
    Trullemans, F.
    Demanet, C.
    De Waele, M.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 110 - 110
  • [9] No evidence for amplification of V617F JAK2 in myeloproliferative disorders
    Jones, A. V.
    Bunyan, D. J.
    LEUKEMIA, 2007, 21 (12) : 2561 - 2563
  • [10] No evidence for amplification of V617F JAK2 in myeloproliferative disorders
    A V Jones
    D J Bunyan
    N C P Cross
    Leukemia, 2007, 21 : 2561 - 2563
12345